← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS INC · Approved 1984-06-07

Drug application

FDA Application #
ANDA062517
Application type
Abbreviated New Drug Application (Generic)
Brand name
NYSTATIN
Generic name
Nystatin
Active ingredients
NYSTATIN
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
FOUGERA PHARMS INC
First approval
1984-06-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown